Clinical trial Recruiting at 2 sites Observational Ages 18 to 99 Women only

Using AI to improve safety in minimally invasive surgery for uterine cancers

Official title: Implementation of Surgical Safety and Intraoperative Metastasis Identification Through Deep Learning: Multicentric Video Collection for Minimally Invasive Sentinel Lymph Node Dissection in Uterine Malignancies

Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06619002 · Data updated 2026-11-12

This study is testing if using AI to analyze surgical videos can make minimally invasive surgeries for uterine cancers safer and help doctors spot problems during the operation.

More Cervical Cancer trials

Quick facts

Study typeObservational
Ages18 Years to 99 Years
SexWomen only
Enrollment100 (estimated)
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
Academic / other
Drugs / interventionsradiation
Locations2 sites (Roma and 1 other locations)
StatusRecruiting
StartedSeptember 17, 2024
Main results expectedSeptember 30, 2026
Study endsSeptember 30, 2027
Registry record updatedOctober 2, 2024
Trial IDNCT06619002 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women over 18 years old who are undergoing minimally invasive sentinel lymph node dissection for endometrial or cervical cancers.

Probably not a fit

Patients with previous pelvic radiotherapy treatments or severe endometriosis may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on enhancing surgical safety and identifying intraoperative metastasis in patients undergoing minimally invasive sentinel lymph node dissection for endometrial and cervical cancers. By utilizing deep learning algorithms to analyze surgical videos, the research aims to document and quantify intraoperative events, thereby identifying potential complications and improving surgical outcomes. The study will collect multicentric video data to develop AI tools that can provide real-time decision support during surgeries. This innovative approach seeks to address the limitations of current sentinel lymph node procedures and improve patient management.

Why it matters

Potential benefit: If successful, this study could significantly reduce surgical complications and improve outcomes for patients with uterine malignancies.

How similar studies have gone: Other studies have shown promise in using AI for surgical video analysis, indicating potential success for this novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women undergoing MIS sentinel lymph node dissection for endometrial or cervical cancers
* Availability of video
* Age \>18 years
* Willingness to participate in the study and to provide informed consent

Exclusion Criteria:

* Previous pelvic radiotherapy treatments
* Severe endometriosis or other conditions able to alter the pelvic anatomy

Where it's running

  • Fondazione Policlinico Universitario A. Gemelli IRCCS
    Roma, Italy
    Recruiting
  • Fondazione Policlinico Universitario A. Gemelli IRCCS
    Rome, Italy
    Recruiting

Study contacts

  • Principal investigator: Matteo PAVONE, MD — Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome Italy; IHU Strasbourg; IRCAD Strasbourg; Icube Strasbourg;
  • Study coordinator: Matteo PAVONE, MD
  • Email: matteo.pavone@guest.policlinicogemelli.it
  • Phone: 00390630151

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.